NEW YORK CITY, Jan. 9, 2017 — Johnson & Johnson Innovation LLC, New York State, and the New York Genome Center today announced a collaboration to launch a new JLABS in New York City. Called JLABS @ NYC, the 30,000-square foot facility will be located at the New York Genome Center (NYGC) in Soho and will open in 2018. The project is receiving $17 million in New York State funding. The site will be open to biotech, pharmaceutical, medical device and consumer health companies. A Quick Fire Challenge seeking companies working in these areas, particularly startups working on cross-sector solutions to prevent intercept or cure diseases, will be launched by Johnson & Johnson Innovation, with the winner(s) eligible for one year of residency at JLABS @ NYC.
